河北医药
河北醫藥
하북의약
HEBEI MEDICAL JOURNAL
2014年
14期
2088-2090
,共3页
贾慧玲%朱叶珊%韩玉娜%雷淼娜%闫宝环
賈慧玲%硃葉珊%韓玉娜%雷淼娜%閆寶環
가혜령%주협산%한옥나%뢰묘나%염보배
溃疡性结肠炎%中药灌肠%动物模型%促炎因子
潰瘍性結腸炎%中藥灌腸%動物模型%促炎因子
궤양성결장염%중약관장%동물모형%촉염인자
ulcerative colitis%Chinese medicine enema%animal model%proinflammatory factor
目的:探讨改良愈疡方对右旋葡聚糖硫酸钠( DSS )诱导的溃疡性结肠炎模型小鼠抗炎作用机制。方法40只雄性C57 BL/6小鼠除正常组外,采用口服DSS造模后,按完全随机法分为模型组、治疗组、对照组,每组10只;正常组和模型组均用0.9%氯化钠溶液灌肠,治疗组动物给与中药灌肠,对照组给与柳氮磺胺吡啶灌肠共14 d。进行结肠肿瘤坏死因子( TNF)-α水平测定及通过免疫组化检测TNF-α在结肠组织中的表达。结果对照组、治疗组治疗前与模型组基本相同,治疗后治疗组的大便较成形、血便及体质量减轻较不明显,一般情况优于模型组及对照组( P <0.05)。 SS小鼠结肠炎结肠组织中TNF-α较正常组显著增高( P <0.05),用中药治疗组则显著降低,且优于对照组( P <0.05)。同时,在模型组小鼠结肠组织中,TNF-α表达主要见于黏膜和黏膜下层,主要集中在靠近糜烂或溃疡的周边,小血管扩张的周围,也相对增多,治疗组TNF-α阳性细胞明显减少,与模型组及对照组比较均有显著差异( P <0.05)。结论改良愈疡方对溃疡性结肠炎模型小鼠具有良好的治疗作用,其作用机制是通过降低TNF-α含量,抑制炎症有关。
目的:探討改良愈瘍方對右鏇葡聚糖硫痠鈉( DSS )誘導的潰瘍性結腸炎模型小鼠抗炎作用機製。方法40隻雄性C57 BL/6小鼠除正常組外,採用口服DSS造模後,按完全隨機法分為模型組、治療組、對照組,每組10隻;正常組和模型組均用0.9%氯化鈉溶液灌腸,治療組動物給與中藥灌腸,對照組給與柳氮磺胺吡啶灌腸共14 d。進行結腸腫瘤壞死因子( TNF)-α水平測定及通過免疫組化檢測TNF-α在結腸組織中的錶達。結果對照組、治療組治療前與模型組基本相同,治療後治療組的大便較成形、血便及體質量減輕較不明顯,一般情況優于模型組及對照組( P <0.05)。 SS小鼠結腸炎結腸組織中TNF-α較正常組顯著增高( P <0.05),用中藥治療組則顯著降低,且優于對照組( P <0.05)。同時,在模型組小鼠結腸組織中,TNF-α錶達主要見于黏膜和黏膜下層,主要集中在靠近糜爛或潰瘍的週邊,小血管擴張的週圍,也相對增多,治療組TNF-α暘性細胞明顯減少,與模型組及對照組比較均有顯著差異( P <0.05)。結論改良愈瘍方對潰瘍性結腸炎模型小鼠具有良好的治療作用,其作用機製是通過降低TNF-α含量,抑製炎癥有關。
목적:탐토개량유양방대우선포취당류산납( DSS )유도적궤양성결장염모형소서항염작용궤제。방법40지웅성C57 BL/6소서제정상조외,채용구복DSS조모후,안완전수궤법분위모형조、치료조、대조조,매조10지;정상조화모형조균용0.9%록화납용액관장,치료조동물급여중약관장,대조조급여류담광알필정관장공14 d。진행결장종류배사인자( TNF)-α수평측정급통과면역조화검측TNF-α재결장조직중적표체。결과대조조、치료조치료전여모형조기본상동,치료후치료조적대편교성형、혈편급체질량감경교불명현,일반정황우우모형조급대조조( P <0.05)。 SS소서결장염결장조직중TNF-α교정상조현저증고( P <0.05),용중약치료조칙현저강저,차우우대조조( P <0.05)。동시,재모형조소서결장조직중,TNF-α표체주요견우점막화점막하층,주요집중재고근미란혹궤양적주변,소혈관확장적주위,야상대증다,치료조TNF-α양성세포명현감소,여모형조급대조조비교균유현저차이( P <0.05)。결론개량유양방대궤양성결장염모형소서구유량호적치료작용,기작용궤제시통과강저TNF-α함량,억제염증유관。
Objective To investigate the mechanism of anti -inflammatory effect of improved Yuyangfang on mouse model with ulcerative colitis (UC) induced by dextran sulfate sodium (DSS).Methods Forty male C57BL/6 mice were randomly divided into four groups:normal control group , model group , treatment group , control group , with 10 mice in each group.Except for normal control group ,the mice in control group ,model group and treatment group were given orally 4%DSS to establish animal models with ulcerative colitis .After the models were successfully established ,the mice in control group and model group were treated with saline enema ,however ,the mice in treatment group were treated with Chinese medicine enema , in addition,the mice in control group were treated with salazosulfapyridine enema for 14 days.The expression level TNF-αin colon tissue were detected by immunohistochemisty .Results After treatment the treatment group was superior to control group and model group in the aspects of stools forming ,bloody stool,body weight lightening and general condition ( P <0.05).The expression level TNF-αin colon tissue of model mice with UC were significantly higher than those in normal control group ( P<0.05),however,which were obviously decreased in treatment group ,moreover,treatment group was superior to control group ( P <0.05).At the same time,the expression of TNF-αin mouse’s colon tissue of model group was mainly found in mucosa and submucosa tissue ,mainly concentrated on the tissues of erosion ,ulcer and small blood vessels dilatation ,TNF-αpositive cells in treatment group were significantly decreased ,as compared with those in model group and control group ( P <0.05). Conclusion The improved Yuyangfang is effective in treating ulcerative colitis in model mice ,and its action mechanism may be related to reducing TNF-αlevels and inhibiting inflammation reaction .